varenicline has been researched along with Body Weight in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Glatard, A; Guidi, M | 1 |
Kanaoka, Y; Kataoka, Y; Koga, M; Kubo, N; Ohishi, K; Ohkido, Y; Sugiyama, K; Yamauchi, A | 1 |
Faessel, H; Ravva, P; Williams, K | 1 |
Mikkelsen, K; Tønnesen, P | 1 |
3 trial(s) available for varenicline and Body Weight
Article | Year |
---|---|
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.
Topics: Adult; Body Weight; Carbon Monoxide; Dose-Response Relationship, Drug; Female; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Models, Biological; Polymorphism, Single Nucleotide; Smokers; Smoking Cessation; Smoking Cessation Agents; Varenicline; Young Adult | 2019 |
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adolescent; Area Under Curve; Benzazepines; Body Weight; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Treatment Outcome; Varenicline | 2009 |
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline | 2013 |
1 other study(ies) available for varenicline and Body Weight
Article | Year |
---|---|
Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Apolipoproteins E; Benzazepines; Body Weight; Cardiovascular Diseases; Cholesterol; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Plaque, Atherosclerotic; Quinoxalines; Varenicline | 2014 |